Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 17.53% vs -15.77% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 49.24% vs -7.60% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 54.66% vs -11.14% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -25.81% vs 55.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Frontier Biotechnologies, Inc. (China) With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.88% vs -25.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 17.53% vs -15.77% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -20.63% vs -458.23% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 49.24% vs -7.60% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -19.47% vs 52.71% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 54.66% vs -11.14% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -4.17% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -25.81% vs 55.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






